journal article·2024-06-28

PEGylated Opto-Magnetic Gold and Silver Sulfide Iron Oxide Nanoprobes for Synergistic Photothermal Therapy

Kheireddine El-Boubbou, Erving Ximendes, Francisco J. Teran, Riccardo Marin, Álvaro Artiga, Dirk H. Ortgies, Daniel Jaque

ACS Applied Nano Materials· Volume 7· Issue 12
Publisher page

Abstract

There is a continuous vivid search for biocompatible hybrid magneto-optical nanoprobes with high heating and photoluminescence efficiencies for photothermal theranostics. Herein, two tailored multipurpose hybrid PEGylated gold (Au) and silver sulfide (Ag 2 S) magnetic iron oxide nanoparticle formulations (Au-PEG-MNPs and Ag 2 S-PEG-MNPs) with unique opto-magnetic properties for simultaneous photothermal therapy were prepared. The physiochemical properties of the hybrid MNPs were fully characterized using various electronic and spectroscopic techniques, showing colloidal stabilized small-sized nanoparticles (core sizes = 10 nm, D H = 200 nm) with high saturation magnetizations ( M s up to 85 emu/g) and superparamagnetic behavior. Thermal effects in response to an alternating magnetic field (AMF) at different frequencies ( f = 25–300 kHz) and field intensities ( H = 12 and 24 kA/m) were assessed using an ultrafast magnetometric method, revealing high heating efficiencies with distinctive heating responses. The “optothermal” efficacies were then evaluated using a unique experimental setup equipped with a highly sensitive thermal camera for recording temperatures in real time, along with a simultaneous clinically safe near-infrared (NIR) laser (λ = 808 nm and power = 0.5 W cm –2 ) and AMF ( H = 12 kA/m, f = 180 kHz) dual effect. Remarkably, when irradiated with an NIR laser and AMF, both hybrid Au- and Ag 2 S-PEG-MNPs displayed superior heat induction power (SAR = 384 and 441 W/g), rapidly reaching hyperthermia temperatures of 42 °C in only a few seconds. Temperatures could reach up to 75 °C for Au-PEG-MNPs and 90 °C for Ag 2 S-PEG-MNPs in only 5 min. Such superior heating efficiencies for the hybrid MNPs increased ∼1.5–2 times under concurrent irradiation compared to the action by laser alone. Finally, cytotoxicity assays against cancerous and normal cells confirmed the safety profiles and low toxicities of the hybrid nanoformulations. This unique synergistic platform has great potential to be utilized for multimodal photothermal therapy with reduced field strengths, laser intensities, and short irradiation times in the unceasing search for tangible hyperthermal clinical nanoprobes.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Nanoplatforms for cancer theranostics · Laser-Ablation Synthesis of Nanoparticles

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, College of Science, University of Bahrain, Sakhir 32038, Kingdom of Bahrain

Nanomaterials for BioImaging Group (nanoBIG), Facultad de Ciencias, Departamento de Física de Materiales, Universidad Autónoma de Madrid (UAM), Madrid 28049, Spain

Nanomaterials for BioImaging Group (nanoBIG), Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Ctra. de Colmenar Km. 9100, Madrid 28034, Spain

iMdea Nanociencia, Campus Universitaria de Cantoblanco, 28049 Madrid, Spain

Nanobiotecnología (iMdea Nanociencia), Unidad Asociada al Centro Nacional de Biotecnología (CSIC), 28049 Madrid, Spain

Funding

Comunidad de Madrid · European Commission · Ministerio de Ciencia e Innovaci?n · University of Bahrain · Arab Fund for Economic and Social Development · Instituto de Salud Carlos III

References (69)

Show source-provided references
1. 10.2217/nnm-2017-033610.2217/nnm-2017-0336 ↗
2. 10.1039/C6NR07542H10.1039/C6NR07542H ↗
3. 10.1016/j.mattod.2015.08.02210.1016/j.mattod.2015.08.022 ↗
4. 10.1021/acs.chemrev.3c0015910.1021/acs.chemrev.3c00159 ↗
5. 10.1039/C6SC04384D10.1039/C6SC04384D ↗
6. 10.1016/j.isci.2021.10218910.1016/j.isci.2021.102189 ↗
7. 10.1021/acsnano.0c0834910.1021/acsnano.0c08349 ↗
8. 10.1021/acsnano.3c0089110.1021/acsnano.3c00891 ↗
9. 10.1021/acsnano.5b0724910.1021/acsnano.5b07249 ↗
10. 10.1021/acsami.6b0994210.1021/acsami.6b09942 ↗
11. 10.1021/acsami.2c2200010.1021/acsami.2c22000 ↗
12. 10.1002/advs.20230220810.1002/advs.202302208 ↗
13. 10.1021/ar800150g10.1021/ar800150g ↗
14. 10.1002/anie.20151040910.1002/anie.201510409 ↗
15. 10.1021/nn301218z10.1021/nn301218z ↗
16. 10.1002/ange.20060247110.1002/ange.200602471 ↗
17. 10.1007/s12274-019-2280-410.1007/s12274-019-2280-4 ↗
18. 10.3390/nano803014910.3390/nano8030149 ↗
19. 10.1186/1477-3155-10-2710.1186/1477-3155-10-27 ↗
20. 10.1016/j.bcp.2021.11463910.1016/j.bcp.2021.114639 ↗
21. 10.1002/chem.20210212310.1002/chem.202102123 ↗
22. 10.1021/nn503694410.1021/nn5036944 ↗
23. 10.1038/nature1237310.1038/nature12373 ↗
24. 10.7150/thno.3809110.7150/thno.38091 ↗
25. 10.1021/acsnano.6b0786610.1021/acsnano.6b07866 ↗
26. 10.1016/j.msec.2019.02.10610.1016/j.msec.2019.02.106 ↗
27. 10.1002/anie.20120605910.1002/anie.201206059 ↗
28. 10.1002/smll.20190717110.1002/smll.201907171 ↗
29. 10.1021/acs.chemrev.0c0069210.1021/acs.chemrev.0c00692 ↗
30. 10.1021/acsami.1c1934410.1021/acsami.1c19344 ↗
31. 10.1002/adfm.20200273010.1002/adfm.202002730 ↗
32. El-Boubbou, K. Acid-stabilized iron-based metal oxide colloidal nanoparticles, and methods thereof. U.S. Patent 10,629,339, 2020.
33. 10.1021/ja055056d10.1021/ja055056d ↗
34. 10.1021/acsami.1c1934410.1021/acsami.1c19344 ↗
35. 10.1021/ja909490r10.1021/ja909490r ↗
36. 10.1021/jp100312e10.1021/jp100312e ↗
37. 10.1016/j.bbrc.2020.06.07210.1016/j.bbrc.2020.06.072 ↗
38. 10.1016/j.colsurfb.2015.05.05110.1016/j.colsurfb.2015.05.051 ↗
39. 10.1039/c0ce00902d10.1039/c0ce00902d ↗
40. 10.1021/ja063662i10.1021/ja063662i ↗
41. 10.1002/anie.20070019710.1002/anie.200700197 ↗
42. 10.1039/C9NR02039J10.1039/C9NR02039J ↗
43. 10.1039/D2RA05990H10.1039/D2RA05990H ↗
44. 10.1021/cr068028210.1021/cr0680282 ↗
45. 10.1073/pnas.223247910010.1073/pnas.2232479100 ↗
46. 10.1007/s42452-021-04456-010.1007/s42452-021-04456-0 ↗
47. 10.1088/0022-3727/38/15/00410.1088/0022-3727/38/15/004 ↗
48. 10.1002/adma.20210007710.1002/adma.202100077 ↗
49. 10.1039/D2NR03413A10.1039/D2NR03413A ↗
50. 10.1039/C6CC03225G10.1039/C6CC03225G ↗
51. 10.2174/156802661466614011820355010.2174/1568026614666140118203550 ↗
52. 10.1039/D1NJ05791J10.1039/D1NJ05791J ↗
53. 10.3390/nano1105120310.3390/nano11051203 ↗
54. 10.1038/s41598-019-40769-210.1038/s41598-019-40769-2 ↗
55. 10.1039/c2jm30472d10.1039/c2jm30472d ↗
56. 10.1039/D4RA01600A10.1039/D4RA01600A ↗
57. 10.1002/smll.20190496010.1002/smll.201904960 ↗
58. 10.3390/app1114663710.3390/app11146637 ↗
59. 10.1063/9.000059210.1063/9.0000592 ↗
60. 10.1002/adfm.20170443410.1002/adfm.201704434 ↗
61. 10.1016/j.jmmm.2006.10.115610.1016/j.jmmm.2006.10.1156 ↗
62. 10.1038/s41598-020-71703-610.1038/s41598-020-71703-6 ↗
63. 10.1016/j.physrep.2023.10.00310.1016/j.physrep.2023.10.003 ↗
64. 10.1080/0265673050015836010.1080/02656730500158360 ↗
65. 10.1089/089277904127171510.1089/0892779041271715 ↗
66. 10.1021/acs.bioconjchem.6b0025710.1021/acs.bioconjchem.6b00257 ↗
67. 10.1038/s41598-020-58605-310.1038/s41598-020-58605-3 ↗
68. 10.1016/j.matlet.2014.04.01410.1016/j.matlet.2014.04.014 ↗
69. 10.1088/0022-3727/47/49/49500310.1088/0022-3727/47/49/495003 ↗